AHA Coding Clinic® for HCPCS - 2020 Quarter 4; For Your Information
HCPCS codes for drugs, biologicals and radiopharmaceuticals with revised long descriptors as of October 1, 2020
There are two long descriptor changes for HCPCS codes J9305 and C9066 effective October 1, 2020. The long descriptor changes are listed in the table on the following page: HCPCS Code Old Long Descriptor New Long DescriptorEffective Date C9066 Injection, sacituzumab govitecan-hziy, 10 mg Injection, sacituzumab govitecan-hziy, 2.5 mg October 1, 2020 J9305 Injection, pemetrexed, 10 mg Injection, pemetrexed, not otherwise specified, 10 mg October 1, 2020 New skin substitute products as of October 1, 2020 There are four new skin substitute HCPCS codes that became active as of October 1, 2020. These codes are listed in the...
Subscribe or sign in to view the full article.
Article Overview
This article reviews HCPCS changes effective October 1, 2020. It covers revised long descriptors for certain drug and biological billing codes and identifies newly active skin substitute product codes. The content is most relevant to coders, billing staff, and reimbursement professionals who track quarterly HCPCS updates and code-set changes.
Why This Topic Matters
Quarterly HCPCS updates can affect charge capture, claims processing, and code lookup workflows. Knowing which drug, biological, radiopharmaceutical, and skin substitute codes changed helps coding and billing teams keep reference files current.
Article Sections
-
HCPCS code descriptor changes
This section presents revised long descriptors for selected HCPCS drug and biological billing codes effective in October 2020. It provides the update context without detailed coding guidance.
-
New skin substitute products
This section lists newly active HCPCS skin substitute product codes effective in October 2020. It focuses on the addition of new product entries and their effective date.
What You Will Learn
- Which HCPCS update categories are covered in the October 2020 release
- What types of HCPCS changes were made for certain drug and biological billing codes
- How newly active skin substitute product codes are presented in the update
- Which effective date applies to the listed HCPCS changes
Who Should Read This
- Medical coders
- Billing staff
- Reimbursement specialists
- Revenue cycle teams
- Healthcare compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com